D-1542-2020 Class II Terminated

Recalled by Par Pharmaceutical Inc. — Chestnut Ridge, NY

FDA drug recall D-1542-2020 was initiated by Par Pharmaceutical Inc. on Aug 10, 2020 and is designated Class II. Reason for recall: Failed Impurity /Degradation Specifications The recall status is terminated (terminated Jun 7, 2021). Affected quantity: 11,347 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 2, 2020
Initiation Date
Aug 10, 2020
Termination Date
Jun 7, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,347 bottles

Product description

BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01

Reason for recall

Failed Impurity /Degradation Specifications

Distribution pattern

Product was distributed to 9 major distributors throughout the United States.

Code information

Lot # 32091002, exp. date May 2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1542-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1542-2020. Report a data issue: hello@regdatalab.com.